✦ LIBER ✦

Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib

✍ Scribed by J. L. Goldstein; G. M. Eisen; N. Agrawal; W. F. Stenson; J. D. Kent; K. M. Verburg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced risk of upper gastrointestinal u

✍ Jay L. Goldstein; Fred E. Silverstein; Naurang M. Agrawal; Richard C. Hubbard; J 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

The gastrointestinal safety of the COX-2

✍ Richard H Hunt; Sean Harper; Douglas J Watson; Chang Yu; Hui Quan; Michael Lee; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

Upper gastrointestinal (UGI) tolerabilit

✍ Goldstein, Jay L.; Eisen, Glenn M.; Hanna, David B.; Burke, Thomas 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 456 KB

COX-2-selective inhibitors and the risk

✍ B. Nørgård; L. Pedersen; S. P. Johnsen; R. E. Tarone; J. K. McLaughlin; S. Friis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

COX-2 inhibitor compared with proton pum

✍ Kam-Chuen Lai; Kent-Man Chu; Wai-Mo Hui; Chun-Yu Wong; Wayne Hu; Wai-Man Yuen; M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Risk of upper gastrointestinal ulcer ble

✍ Lanas, A; Garcia-Rodriguez, L A; Arroyo, M T; Gomollon, F; Feu, F; Gonzalez-Pere 📂 Article 📅 2006 🏛 BMJ Publishing Group 🌐 English ⚖ 228 KB